The Current Ratio as of September 2024 (TTM) for DiaMedica Therapeutics Inc. (DMAC) is 17.82

According to DiaMedica Therapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 17.82. This represents a change of -7.80% compared to the average of 19.32 of the last 4 quarters.

DiaMedica Therapeutics Inc. (DMAC) Historical Current Ratio (quarterly & annually)

How has DMAC Current Ratio performed in the past?

The mean historical Current Ratio of DiaMedica Therapeutics Inc. over the last ten years is 10.38. The current 17.82 Current Ratio has changed 17.06% with respect to the historical average. Over the past ten years (40 quarters), DMAC's Current Ratio was at its highest in in the September 2021 quarter at 29.89. The Current Ratio was at its lowest in in the December 2014 quarter at 0.15.

DiaMedica Therapeutics Inc. (DMAC) Current Ratio by Quarter and Year

Discovering the peaks and valleys of DiaMedica Therapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

DiaMedica Therapeutics Inc. (DMAC) Average Current Ratio

How has DMAC Current Ratio performed in the past?

The current Current Ratio of DiaMedica Therapeutics Inc. (DMAC) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

DiaMedica Therapeutics Inc. (DMAC) Current Ratio vs. Peers

How is DMAC’s Current Ratio compared to its peers?

DiaMedica Therapeutics Inc.’s Current Ratio is less than Milestone Pharmaceuticals Inc. (19.13), greater than Seres Therapeutics, Inc. (1.38), greater than Inhibikase Therapeutics, Inc. (2.32), greater than Oncolytics Biotech Inc. (4.99), greater than scPharmaceuticals Inc. (4.84), greater than aTyr Pharma, Inc. (6.07), greater than Lyra Therapeutics, Inc. (3.60), greater than Centessa Pharmaceuticals plc (13.29), greater than Iovance Biotherapeutics, Inc. (5.15), less than X4 Pharmaceuticals, Inc. (0), greater than Galera Therapeutics, Inc. (6.07), greater than Terns Pharmaceuticals, Inc. (5.63), less than Day One Biopharmaceuticals, Inc. (21.02), greater than HOOKIPA Pharma Inc. (4.09), greater than null (3.86),

Build a custom stock screener for DiaMedica Therapeutics Inc. (DMAC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DiaMedica Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

DiaMedica Therapeutics Inc. (DMAC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like DiaMedica Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.